REG - Induction Healthcare - Publication of Annual Report & Notice of AGM

Induction HealthcareAnnouncement

28/09/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210928:nRSb1219Na&default-theme=true

RNS Number : 1219N  Induction Healthcare Group PLC   28 September 2021

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Publication of Annual Financial Report & Notice of AGM

 

Induction (AIM: INHC), a leading virtual care platform driving digital
transformation of healthcare systems worldwide, announces that the Annual
Report and Accounts, Notice of Annual General Meeting ("AGM") and associated
Form of Proxy, available on the Company's website, have been posted to those
shareholders who have opted out of electronic communications.

 

The documents are available here:
https://inductionhealthcare.com/investors/financial-reports-and-publications/
(https://inductionhealthcare.com/investors/financial-reports-and-publications/)
 

 

The Company's AGM will be held at 50 Liverpool Street, London EC2M 7PY at
09.00 am on Thursday 4 November 2021.

 

In light of the recent easing by the UK Government of COVID-19 restrictions,
the Company anticipates that it will be able to hold the AGM in the normal way
this year. If so, this will mean that shareholders will be welcome to attend
the AGM in person. However, given the constantly evolving nature of the
situation, should the COVID-19 restrictions change such that the Company
considers it is no longer possible for shareholders to attend the meeting, the
AGM will be held as a closed meeting instead. In the event that the AGM
arrangements have to change, the Company will issue a further communication
via a regulatory information service and on the Company website at
https://inductionhealthcare.com/investors/
(https://inductionhealthcare.com/investors/) .

 

Shareholders are therefore strongly encouraged to complete and return the Form
of Proxy in accordance with the instructions set out therein to the Company's
registrars, Equiniti Limited, Aspect House, Spencer Road, Lancing, West
Sussex, BN99 6DA, as soon as possible but in any event so as to arrive no
later than 09.00 am on Tuesday 2 November 2021. Given the potential
restrictions on attendance, members are strongly encouraged to appoint the
'Chair of the Meeting' as their proxy rather than a named person who may not
be permitted to attend the meeting.

 

Alternatively, eligible shareholders who hold their shares in the Company in
uncertificated form in CREST may use the CREST Proxy Voting Service, details
in respect of which are contained in the notes to the notice of the AGM.
Electronic Proxy Appointment ('EPA') is also available for this meeting. To
use this facility, investors must visit www.sharevote.co.uk where details of
the procedure are shown. Details on how to lodge your vote electronically are
contained within the notes to the Notice of AGM.

 

The results of voting on the resolutions will be announced via a regulatory
information service and posted on the Company's website as soon as practicable
possible after the AGM.

 

In order to give shareholders a chance to engage in a meaningful dialogue with
the Company's management, please email the Company Secretary at
Alison.t@inductionhealthcare.com (mailto:Alison.t@inductionhealthcare.com)
with any questions on the business of the AGM or the Report and Accounts in
advance of the meeting stating your name (as printed on your Form of Proxy).
The questions will be collated and a representative sample will be selected
and answered on the Company's website at https://inductionhealthcare.com/
(https://inductionhealthcare.com/) as soon as practicable after the conclusion
of the AGM.

 

 

 

-ENDS-

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

                                                      (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer

 Dr Hugo Stephenson, Group Executive Director

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Alice Woodings                          Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) is a leading virtual care platform driving digital
transformation of healthcare systems worldwide. Induction solutions enhance
the investments hospitals have made and lay the foundation for their future.
Our products can enable information sharing between busy doctors, alleviate
operational burdens on hospitals or put patients in better control of their
care, all while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the limitations of
paper-based and desktop systems, creating substantial time and cost
efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the
UK, Ireland, Australia and South Africa, as well as a rapidly growing number
of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK,
used by the majority of hospital doctors within the NHS. The app helps to
increase productivity and enhance communication by securely sharing phone
numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital
trusts within the NHS, with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. This increases knowledge of, and adherence to,
guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting
hospitals. The platform allows patients to book and access their appointments,
read their clinical letters, store a copy of their clinical record and provide
data to their care teams remotely. It is not just a compelling patient
experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video
consultations. It helps hospitals, health systems and other customers offer
video consultations to patients and service users as a normal part of
day-to-day clinical activity. Our vision is for video consultations to improve
lives and help address social, access, equity and sustainability challenges by
allowing healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads
and writes patient demographic, appointment and clinical record data between a
growing number of hospital EHR systems and the Induction platforms. This
connectivity between stakeholders and legacy IT systems adds substantial value
to pre-existing health IT investment and allows large-scale adoption of
Induction app-based services.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAFLFEEADIDFIL